| abstract |
The present invention relates to compounds of formula (I), any of it enantiomers, or any mixture thereof, or a pharmaceutically acceptable acid addition salt thereof, wherein R1, R2, R3, R4, R11, R12, R13, R14 and R15 each independently are hydrogen, alkyl, alkoxy, halogen, trifluoromethyl, nitro, cyano, amino, acyl, alkylamino, dialkylamino, aminocarbonyl, or acylamino; R5 is hydrogen, alkyl, alkoxyalkyl, or phenylalkyl; X is -CH2-Z-, Z-CH2-, NH-CO-, -CO-NH-, or -CH=CH-; wherein Z is O, S, CH2, or NH; Y is O, -CH2-W-, -W-CH2-; wherein W is O, or S; and n is 0, 1 or 2. The compounds are useful in the treatment of psychotic disorders. |